vTv Therapeutics grants 23,500 inducement stock options at weighted average exercise price of $31.95 per share
VTVT•Inducement stock option grants
vTv Therapeutics granted 23,500 stock options to two non-executive employees under its 2026 Inducement Plan.
The options carried a weighted average exercise price of $31.95 per share. The awards vest over four years, with 25% vesting after one year and the remainder vesting quarterly over the next 36 months, subject to continued employment.
The options have a 10-year term.
